Olanzapine 10-N-glucuronide: A tertiary N-glucuronide unique to humans

Drug Metabolism and Disposition

Volumn 26, Issue 9, 1998, Pages 848-855

  Kassahun, Kelem ^a   Mattiuz, Edward ^c   Franklin, Ronald ^b   Gillespie, Todd ^c  

^a MERCK RESEARCH LABORATORIES   (United States)

^b AMGEN INC   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLUCURONIDE; NEUROLEPTIC AGENT; OLANZAPINE;

CONFERENCE PAPER; DRUG DEGRADATION; DRUG DISPOSITION; DRUG GLUCURONIDATION; HUMAN; NORMAL HUMAN; PRIORITY JOURNAL; XENOBIOTIC METABOLISM;

ANIMALS; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; GLUCURONATES; HUMANS; PIRENZEPINE;

EID: 0031657686     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (11)

1. Baldwin DS and Montgomery SA (1995) First clinical experience with olanzapine (LY170053): Results of an open-label safety and dose ranging study in patients with schizophrenia. Int Clin Psychopharmacol 10:239-244.
2. Beasley CM, Sanger T, Satterlee W, Tollefson G, Tran P and Hamilton S (1996b) Olanzapine versus placebo: Results of a double-blind, fixed-dose olanzapine trial. Psychopharmacology 124:159-167.
3. Beasley CM, Tollefson G, Tran P, Satterlee W, Sanger T and Hamilton S (1996a) Olanzapine versus placebo and haloperidol: Acute phase results of the North American double-blind olanzapine trial. Neuropsychopharmacology 14:111-123.
4. Catlow JT, Barton RD, Clemens M, Gillespie TA, Goodwin M and Swanson SP (1995) Analysis of olanzapine in human plasma utilizing reversed-phase high performance liquid chromatography with electrochemical detection. J Chromatogr B 668:85-90.
5. Chaudhuri NK, Servando OA, Manniello MJ, Luders RC and Chao DK (1976) Metabolism of tripelennamine in man. Drug Metab Dispos 4:372-378.
6. Chiu JA and Franklin RB (1996) Analysis and pharmacokinetics of olanzapine (LY170053) and two metabolites in rat plasma using reversed phase HPLC with electrochemical detection. J Pharmaceut Biomed Anal 14:609-615.
7. Fischer LJ, Thies RL, Charkowski D and Donham KJ (1980) Formation and urinary excretion of cyproheptadine glucuronide in monkeys, chimpanzees and humans. Drug Metab Dispos 6:422-424.
8. Hucker HB, Stauffer SC, Balletto AJ, White SD, Zacchei AG and Arison BH (1978) Physiological disposition and metabolism of cyclobenzaprine in the rat, dog, rhesus monkey and man. Drug Metab Dispos 6:659-672.
9. Kassahun K, Mattiuz E, Nyhart E, Obermeyer B, Gillespie T, Murphy A, Goodwin RM, Tupper D, Callaghan JT and Lemberger L (1997) The disposition and biotransformation of the antipsychotic agent olanzapine in humans. Drug Metab Dispos 25:81-93.
10. +-glucuronide in the urine of patients treated with clozapine using electrospray mass spectrometry. Biol Mass Spectrometry 23:147-148.
11. Mattiuz E, Franklin R, Gillespie T, Murphy A, Bernstein J, Chiu A, Hotten T and Kassahun K (1997) Disposition and metabolism of olanzapine in mice, dogs and rhesus monkeys. Drug Metab Dispos 25:573-583.